西班牙的催眠药消费:特征和时间趋势,2005-2022年
Nerea Mourino1, Ana Teijeiro1, Carla Guerra-Tort1
1Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela (A Coruña), Spain.
Gaceta sanitaria
|November 27, 2024
概括
在西班牙,从2005年到2022年,催眠药的使用显著增加,特别是在老年女性中. 存在区域差异,突出需要更新成计划和预防策略.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 成研究 研究成研究
背景情况:
- 催眠药物被广泛用于睡眠和焦虑障碍.
- 了解它们的使用趋势对于公共卫生监测和干预至关重要.
- 以前的研究表明,在不同的人群中,精神药物消费的模式不同.
研究的目的:
- 分析从2005年到2022年西班牙使用催眠药的时间演变.
- 为了确定催眠消费模式的区域差异.
- 描述催眠使用者的人口和社会特征.
主要方法:
- 利用了西班牙 (2005-2022) 酒精和其他毒品使用调查的数据.
- 通过性别,年龄和自治社区分析过去30天的催眠使用情况.
- 雇员加入点回归模型来评估流行趋势和用户特征的多变量逻辑回归.
主要成果:
- 在西班牙,催眠药的使用率从3.7% (2005年) 增加到9.7% (2022年),每年增长4.7%.
- 在55-64岁的女性中观察到的最显著的增长,到2022年达到21.4%的流行率.
- 在所有地区都注意到使用量增加,女性,老年人,受教育程度较低,失业者和其他物质使用者的可能性更高.
结论:
- 自2005年以来,西班牙催眠药使用的持续上升趋势是明显的.
- 基于性别,年龄和地理位置存在显著差异.
- 紧急更新区域成计划,加强预防和跨学科合作是必要的,以解决不平等问题并确保负责任的处方.
关键词:
成行为成行为.大人的成年人.大人的成年人.导体添加性 导体添加性西班牙西班牙西班牙西班牙西班牙西班牙催眠剂和镇静剂的使用催眠药和镇静剂的使用流行程度 流行程度流行程度 流行程度 流行程度西班牙西班牙西班牙西班牙西班牙更多相关视频
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
10.9K
05:59Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
2.3K
相关概念视频
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
194
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
194
01:20Sedatives and Hypnotics Drugs: Barbiturates
196
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
196
01:23Sedatives and Hypnotics: Overview
279
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
279
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
01:14CNS Depressants: Barbiturates and Benzodiazepines
224
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
224
01:19Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231